Open AccessSIROLIMUS (SRL) CONCENTRATIONS, DOSES, AND PHARMACODYNAMICS IN HIGH-RISK RENAL ALLOGRAFT PATIENTS RECEIVING EITHER SRL/TACROLIMUS (TAC) OR SRL/ CYCLOSPORINE (CsA) IMMUNOSUPPRESSION.
Author(s) -
AUTHOR_ID
Publication year - 2006
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200607152-00698
Subject(s) - tacrolimus , sirolimus , immunosuppression , medicine , pharmacodynamics , renal transplant , pharmacology , urology , transplantation , pharmacokinetics